DE69623303D1 - Pufferzusammensetzung fur immunologische reagenzien - Google Patents

Pufferzusammensetzung fur immunologische reagenzien

Info

Publication number
DE69623303D1
DE69623303D1 DE69623303T DE69623303T DE69623303D1 DE 69623303 D1 DE69623303 D1 DE 69623303D1 DE 69623303 T DE69623303 T DE 69623303T DE 69623303 T DE69623303 T DE 69623303T DE 69623303 D1 DE69623303 D1 DE 69623303D1
Authority
DE
Germany
Prior art keywords
composition
buffer composition
buffer
immunological reagents
biological
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69623303T
Other languages
English (en)
Other versions
DE69623303T2 (de
Inventor
D Figard
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abbott Laboratories
Original Assignee
Abbott Laboratories
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Laboratories filed Critical Abbott Laboratories
Publication of DE69623303D1 publication Critical patent/DE69623303D1/de
Application granted granted Critical
Publication of DE69623303T2 publication Critical patent/DE69623303T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531—Production of immunochemical test materials
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/5306—Improving reaction conditions, e.g. reduction of non-specific binding, promotion of specific binding
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54393—Improving reaction conditions or stability, e.g. by coating or irradiation of surface, by reduction of non-specific binding, by promotion of specific binding
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/576—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis
    • G01N33/5767—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis non-A, non-B hepatitis
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/82—Hepatitis associated antigens and antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/826—Additives, e.g. buffers, diluents, preservatives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Analytical Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Detergent Compositions (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
DE69623303T 1995-06-07 1996-05-24 Pufferzusammensetzung fur immunologische reagenzien Expired - Fee Related DE69623303T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/482,710 US5616460A (en) 1995-06-07 1995-06-07 Buffer composition for reagents for immunoassay
PCT/US1996/007745 WO1996041164A1 (en) 1995-06-07 1996-05-24 Buffer composition for reagents for immunoassay

Publications (2)

Publication Number Publication Date
DE69623303D1 true DE69623303D1 (de) 2002-10-02
DE69623303T2 DE69623303T2 (de) 2003-04-17

Family

ID=23917128

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69623303T Expired - Fee Related DE69623303T2 (de) 1995-06-07 1996-05-24 Pufferzusammensetzung fur immunologische reagenzien

Country Status (7)

Country Link
US (2) US5616460A (de)
EP (1) EP0852009B1 (de)
JP (2) JP4101874B2 (de)
AT (1) ATE223046T1 (de)
DE (1) DE69623303T2 (de)
ES (1) ES2184866T3 (de)
WO (1) WO1996041164A1 (de)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6171586B1 (en) 1997-06-13 2001-01-09 Genentech, Inc. Antibody formulation
JP3919235B2 (ja) * 1997-06-13 2007-05-23 ジェネンテク，インコーポレイテッド 抗体製剤
US6991790B1 (en) 1997-06-13 2006-01-31 Genentech, Inc. Antibody formulation
AU9497998A (en) 1997-09-22 1999-04-12 Chiron Corporation Method for detecting antibodies in a sample
JP4427182B2 (ja) * 1997-09-22 2010-03-03 ノバルティス バクシンズ アンド ダイアグノスティックス，インコーポレーテッド 抗原を安定化するための緩衝液
CZ298268B6 (cs) * 1998-04-17 2007-08-08 Innogenetics N. V. Imunodiagnostický test používající redukující cinidla
KR100847586B1 (ko) 1998-07-30 2008-07-22 가부시끼가이샤 센단세메이가가꾸겐큐죠 Ｃ형 간염 바이러스의 측정방법
US6623921B2 (en) 1998-07-30 2003-09-23 Advanced Life Science Institute, Inc. Method for measurement of hepatitis C virus
DE10013794A1 (de) * 2000-03-15 2001-10-11 Gluesenkamp Karl Heinz Herstellung, Stabilisierung und Anwendung einer neuen Art von chemisch aktivierten Oberflächen
AU2001273264A1 (en) * 2000-07-21 2002-02-05 Cuno, Incorporated Improved blocking chemistries for nylon membrane
EP1311860A2 (de) * 2000-08-21 2003-05-21 Queen's University At Kingston Verfahren und testkit zur auftrennung und zum nachweis von proteinen in biologischen proben
US20030170618A1 (en) * 2001-02-02 2003-09-11 Chien David Y. Buffers for stabilizing antigens
AU785380B2 (en) * 2001-03-28 2007-03-15 Ortho-Clinical Diagnostics, Inc. A hepatitis C antigen - antibody combination assay for the early detection of HCV infection
JP2003066047A (ja) * 2001-06-14 2003-03-05 Matsushita Electric Ind Co Ltd 免疫反応測定方法及びそれに用いる免疫反応測定用試薬
US7101683B2 (en) 2001-06-26 2006-09-05 Abbott Laboratories Methods for the simultaneous detection of HCV antigens and HCV antibodies
CH698246B1 (de) * 2001-12-20 2009-06-30 Hoffmann La Roche Test zur Identifizierung von Inhibitoren von Beta-Sekretasen.
US20030157556A1 (en) * 2002-02-13 2003-08-21 Maggiore Jack A. Biological fluid stabilizing composition and method of use thereof
AU2003238767A1 (en) * 2002-05-31 2003-12-19 Penn State Research Foundation Dot-elisa for the detection of animal viruses
US20040152070A1 (en) * 2003-02-04 2004-08-05 Shah Dinesh O. Method of detection of HCV antibodies in combination assay or sole antibody assay
US20050014136A1 (en) * 2003-05-28 2005-01-20 Innogenetics N.V. Modified HCV NS5
CA2544185C (en) * 2003-10-28 2010-09-28 Advanced Life Science Institute, Inc. Method of detecting hepatitis c virus
US8877514B2 (en) * 2004-02-26 2014-11-04 Candor Bioscience Gmbh Aqueous solution for use as medium for the specific binding reaction of a binding pair
CN104090097B (zh) * 2004-02-26 2017-04-12 康多尔生物技术有限公司 一种用作结合对的特异性结合反应培养基的水溶液
US7867443B2 (en) * 2004-07-23 2011-01-11 Dako Denmark A/S Method and apparatus for automated pre-treatment and processing of biological samples
US20080108147A1 (en) * 2006-11-03 2008-05-08 Tie Wei Reduction of non-specific binding in immunoassays
JP2007084579A (ja) * 2006-12-28 2007-04-05 Mitsubishi Pharma Corp ヘパリン溶液入りプレフィルドシリンジ製剤およびその製造方法
US8617820B2 (en) * 2007-08-28 2013-12-31 Ortho-Clinical Diagnostics, Inc. Use of glycosaminoglycans to reduce non-specific binding in immunoassays
JP5416159B2 (ja) * 2011-03-31 2014-02-12 富士フイルム株式会社 高感度なイムノクロマトグラフ方法
CN103630690B (zh) * 2013-12-17 2014-08-20 朱之炜 丙型肝炎病毒抗原抗体联合检测试剂盒及其检测方法
WO2016127318A1 (zh) * 2015-02-10 2016-08-18 深圳市新产业生物医学工程股份有限公司 心肌肌钙蛋白i超敏检测试剂盒及其超敏检测方法
CN114200125B (zh) * 2021-12-06 2024-02-13 武汉生之源生物科技股份有限公司 一种不含蛋白的碱性磷酸酶-抗体偶联物稀释液及其制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59198999A (ja) * 1983-04-27 1984-11-10 Denka Seiken Co Ltd クレアチンキナ−ゼ測定用組成物
JPS6339582A (ja) * 1986-08-04 1988-02-20 Takara Shuzo Co Ltd 酵素組成物
US4956274A (en) * 1987-04-06 1990-09-11 Microgenics Corporation Reagent stabilization in enzyme-donor and acceptor assay
US5075221A (en) * 1988-10-07 1991-12-24 Eastman Kodak Company Stabilized extraction composition containing a sulfhydryl-containing reducing agent and its use in chlamydial and gonococcal determinations
EP0401379B1 (de) * 1988-12-06 1994-06-15 Otsuka Pharmaceutical Co., Ltd. Stabilisierte interleukin-1-beta enthaltende zusammensetzung
CA2079912C (en) * 1990-04-06 2000-07-11 Gregory Reyes Hepatitis c virus epitopes
CA2119013A1 (en) * 1991-09-16 1993-04-01 Richard R. Lesniewski Hepatitis c assay
US5376313A (en) * 1992-03-27 1994-12-27 Abbott Laboratories Injection molding a plastic assay cuvette having low birefringence
GR1001480B (el) * 1992-12-29 1994-02-28 Eyaggelia Protopapa Ενζυμικά σκευάσματα περιέχοντα παπαϊνη ή χυμο?ρυψίνη και μέ?οδοι μόνιμης ενζυμικής αποτρίχωσης.

Also Published As

Publication number Publication date
ES2184866T3 (es) 2003-04-16
US5616460A (en) 1997-04-01
JP3930519B2 (ja) 2007-06-13
DE69623303T2 (de) 2003-04-17
WO1996041164A1 (en) 1996-12-19
EP0852009B1 (de) 2002-08-28
EP0852009A1 (de) 1998-07-08
US5773212A (en) 1998-06-30
JP2005300552A (ja) 2005-10-27
JP2001516440A (ja) 2001-09-25
JP4101874B2 (ja) 2008-06-18
ATE223046T1 (de) 2002-09-15

Similar Documents

Publication Publication Date Title
ATE223046T1 (de) Pufferzusammensetzung fur immunologische reagenzien
KR840005083A (ko) 항고혈압제로서 유용한 아미노산유도체의 제조방법
JPS646861A (en) Chromogen cryptahemispherand and use thereof for detection of electrolyte in water inspection sample
FI895959A0 (fi) Komposition, diagnostisk bruksfoerpackning och foerfarande foer snabb detektering av antikroppar.
KR880007059A (ko) 염화리소짐 및 글리치르히진산 디칼륨 함유 수용액 제제
SE7813352L (sv) Nya 2-pyrrolidonforeningar och forfarande for framstellning av desamma
KR900015612A (ko) 글루타르알데하이드와 1,2-벤즈이소티아졸린-3-온의 수성 농축 용액
NO895002D0 (no) Enzymhemmende aminosyrederivater.
FR2449712A1 (fr) Procede pour augmenter l'eclat du calcaire
SE8303136D0 (sv) Derives de lŸoxazolidinone-2 n-arylee optiquement actifs, inhibiteurs specifiques et reversibles de la monoamine oxydase de type b et leur procede de preparation
CA2221556A1 (en) Buffer composition for reagents for immunoassay
KR830006281A (ko) 비스글리코시일 모라노린 유도체의 제조법
ES2174858T3 (es) Procedimiento para determinar el contenido de fructosamina.
ES2106680B1 (es) Composiciones acuosas conteniendo ciprofloxacino y utilizacion y procedimiento correspondientes.
KR910000746A (ko) 1, 1-디옥소페닐실리노일 옥시메틸 d-6-[x-(메틸렌 아미노)페닐-아세트아미도]-페니실라네이트와 그의 파라-톨루엔술폰산염
DE69807059D1 (de) Enzym-konzentrat
AU3577295A (en) Reagent for the determination of free radicals
ES2006700B3 (es) Nuevos derivados de tironina.
KR890015021A (ko) 칼슘분석시약
KR920019742A (ko) L-프롤린 유도체의 제조방법
KR840000482A (ko) 시스틴 유도체의 제조방법
KR860006459A (ko) 신규의 수용성 벤조티아진 디옥사이드 염의 제조방법
KR860002487A (ko) 후란 유도체의 제조방법

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee